Nationwide database analysis of insomnia, depression, and sleeping pill prescriptions in hepatocellular carcinoma patients

References

• Roach M, Juday T, Tuly R, et al. Challenges and opportunities in insomnia disorder. Int J Neurosci. 2020;1:1–8.
   Google Scholar
• Akman T, Yavuzsen T, Sevgen Z, et al. Evaluation of sleep disorders in cancer patients based on pittsburgh sleep quality index. Eur J Cancer Care. 2015;24(4):553–559.
   PubMed Web of Science ®Google Scholar
• Nzwalo I, Aboim MA, Joaquim N, et al. Systematic review of the prevalence, predictors, and treatment of insomnia in palliative care. Am J Hosp Palliat Care. 2020;37(11):957–969.
   PubMed Web of Science ®Google Scholar
• Mogavero MP, DelRosso LM, Fanfulla F, et al. Sleep disorders and cancer: state of the art and future perspectives. Sleep Med Rev. 2021;56:101409.
   PubMed Web of Science ®Google Scholar
• Ataseven B, Frindte J, Harter P, et al. Perception of side effects associated with anticancer treatment in women with breast or ovarian cancer (KEM-GO-1): a prospective trial. Support Care Cancer. 2020;28(8):3605–3615.
   PubMed Web of Science ®Google Scholar
• Imanian M, Imanian M, Karimyar M. Sleep quality and fatigue among breast cancer patients undergoing chemotherapy. Int J Hematol Oncol Stem Cell Res. 2019;13:196–200.
   PubMedGoogle Scholar
• He Y, Meng Z, Jia Q, et al. Sleep quality of patients with differentiated thyroid cancer. PLoS One. 2015;10(6):e0130634.
   PubMed Web of Science ®Google Scholar
• Belloumi N, Maalej Bellaj S, Bachouche I, et al. Comparison of sleep quality before and after chemotherapy in locally advanced nonsmall cell lung cancer patients: a prospective study. Sleep Disord. 2020;2020:8235238.
   PubMedGoogle Scholar
• Rampes S, Ma K, Divecha YA, et al. Postoperative sleep disorders and their potential impacts on surgical outcomes. J Biomed Res. 2019;34(4):271–280.
   PubMed Web of Science ®Google Scholar
• Wang Q, Yu C. Negative role of sleep disturbance in the recovery of gastrointestinal postoperative patients. Expert Rev Gastroenterol Hepatol. 2020;14(4):229–230.
   PubMed Web of Science ®Google Scholar
• Reynolds-Cowie P, Fleming L. Living with persistent insomnia after cancer: a qualitative analysis of impact and management. Br J Health Psychol. 2021;26(1):33–49.
   PubMed Web of Science ®Google Scholar
• Sateia MJ, Buysse DJ, Krystal AD, et al. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American academy of sleep medicine clinical practice guideline. J Clin Sleep Med. 2017;13(2):307–349.
   PubMed Web of Science ®Google Scholar
• Strollo SE, Fallon EA, Gapstur SM, et al. Cancer-related problems, sleep quality, and sleep disturbance among long-term cancer survivors at 9-years post diagnosis. Sleep Med. 2020;65:177–185.
   PubMed Web of Science ®Google Scholar
• Schroeck JL, Ford J, Conway EL, et al. Review of safety and efficacy of sleep medicines in older adults. Clin Ther. 2016;38(11):2340–2372.
   PubMed Web of Science ®Google Scholar
• Tom SE, Wickwire EM, Park Y, et al. Nonbenzodiazepine sedative hypnotics and risk of fall-related injury. Sleep. 2016;39(5):1009–1014.
   PubMed Web of Science ®Google Scholar
• Treves N, Perlman A, Kolenberg Geron L, et al. Z-drugs and risk for falls and fractures in older adults-a systematic review and meta-analysis. Age Ageing. 2018;47(2):201–208.
   PubMed Web of Science ®Google Scholar
• Sys J, Cleynenbreugel SV, Deschodt M, et al. Efficacy and safety of non-benzodiazepine and non-Z-drug hypnotic medication for insomnia in older people: a systematic literature review. Eur J Clin Pharmacol. 2020;76(3):363–381.
   PubMed Web of Science ®Google Scholar
• Richardson K, Savva GM, Boyd PJ, et al. Non-benzodiazepine hypnotic use for sleep disturbance in people aged over 55 years living with dementia: a series of cohort studies. Health Technol Assess. 2021;25(1):1–202.
   Web of Science ®Google Scholar
• Akada K, Koyama N, Taniguchi S, et al. Database analysis of patients with hepatocellular carcinoma and treatment flow in early and advanced stages. Pharmacol Res Perspect. 2019;7(4):e00486.
   PubMed Web of Science ®Google Scholar
• Akada K, Koyama N, Miura T, et al. Real-world database analysis of the characteristics and treatment patterns of patients with endometrial cancer in Japan. Curr Med Res Opin. 2021;37(7):1171–1178.
   PubMed Web of Science ®Google Scholar
• Yang JD, Hainaut P, Gores GJ, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589–604.
   PubMed Web of Science ®Google Scholar
• Singal AG, Mittal S, Yerokun OA, et al. Hepatocellular carcinoma screening associated with early tumor detection and improved survival among patients with cirrhosis in the US. Am J Med. 2017;130(9):1099–1106.e1.
   PubMed Web of Science ®Google Scholar
• Kudo M, Izumi N, Kokudo N, et al. Report of the 21st nationwide follow-up survey of primary liver cancer in Japan (2010–2011). Hepatol Res. 2021;51(4):355–405.
   PubMed Web of Science ®Google Scholar
• Wang S, Sun H, Xie Z, et al. Improved survival of patients with hepatocellular carcinoma and disparities by age, race, and socioeconomic status by decade, 1983-2012. Oncotarget. 2016;7(37):59820–59833.
   PubMedGoogle Scholar
• Ince V, Akbulut S, Otan E, et al. Liver transplantation for hepatocellular carcinoma: malatya experience and proposals for expanded criteria. J Gastrointest Cancer. 2020;51(3):998–1005.
   PubMed Web of Science ®Google Scholar
• Baskiran A, Akbulut S, Sahin TT, et al. Effect of HBV-HDV co-infection on HBV-HCC co-recurrence in patients undergoing living donor liver transplantation. Hepatol Int. 2020;14(5):869–880.
   PubMed Web of Science ®Google Scholar
• Bruyneel M, Sersté T. Sleep disturbances in patients with liver cirrhosis: prevalence, impact, and management challenges. Nat Sci Sleep. 2018;10:369–375.
   PubMed Web of Science ®Google Scholar
• Marin-Alejandre BA, Abete I, Cantero I, et al. Association between sleep disturbances and liver status in obese subjects with nonalcoholic fatty liver disease: a comparison with healthy controls. Nutrients. 2019;11(2):322.
   PubMed Web of Science ®Google Scholar
• Peng JK, Hepgul N, Higginson IJ, et al. Symptom prevalence and quality of life of patients with end-stage liver disease: a systematic review and meta-analysis. Palliat Med. 2019;33(1):24–36.
   PubMed Web of Science ®Google Scholar
• Huang X, Zhang H, Qu C, et al. Depression and insomnia are closely associated with thyroid hormone levels in chronic hepatitis B. Med Sci Monit. 2019;25:2672–2678.
   PubMed Web of Science ®Google Scholar
• Ichikawa T, Miyaaki H, Miuma S, et al. Direct-acting antivirals improved the quality of life, ameliorated disease-related symptoms, and augmented muscle volume three years later in patients with hepatitis C virus. Intern Med. 2020;59(21):2653–2660.
   PubMed Web of Science ®Google Scholar
• Gençdal G, Türker G, Yazici Gençdal I, et al. Assessment of sleep pattern and quality before and after liver transplantation using different methods. Turk J Gastroenterol. 2020;31:581–587.
   PubMed Web of Science ®Google Scholar
• Bruyneel M, Sersté T, Libert W, et al. Improvement of sleep architecture parameters in cirrhotic patients with recurrent hepatic encephalopathy with the use of rifaximin. Eur J Gastroenterol Hepatol. 2017;29:302–308.
   PubMed Web of Science ®Google Scholar
• Singh J, Sharma BC, Puri V, et al. Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy. Metab Brain Dis. 2017;32(2):595–605.
   PubMed Web of Science ®Google Scholar
• Pan F, Tian J, Cicuttini F, et al. Sleep disturbance and bone mineral density, risk of falls and fracture: results from a 10.7-year prospective cohort study. Bone. 2021;147:115938.
   PubMed Web of Science ®Google Scholar
• Kamimura K, Sakamaki A, Kamimura H, et al. Considerations of elderly factors to manage the complication of liver cirrhosis in elderly patients. World J Gastroenterol. 2019;25(15):1817–1827.
   PubMed Web of Science ®Google Scholar
• Nishikawa H, Yoh K, Enomoto H, et al. Frailty and sleep disorder in chronic liver diseases. Life (Basel). 2020;10(8):137.
   PubMed Web of Science ®Google Scholar
• Soriano G, Román E, Córdoba J, et al. Cognitive dysfunction in cirrhosis is associated with falls: a prospective study. Hepatology. 2012;55(6):1922–1930.
   PubMed Web of Science ®Google Scholar
• Kirstein MM, Schweitzer N, Winter T, et al. Patterns and challenges of treatment sequencing in patients with hepatocellular carcinoma: experience from a German referral center. J Gastroenterol Hepatol. 2017;32(10):1730–1738.
   PubMed Web of Science ®Google Scholar
• Gray SH, White JA, Li P, et al. A SEER database analysis of the survival advantage of transarterial chemoembolization for hepatocellular carcinoma: an underutilized therapy. J Vasc Interv Radiol. 2017;28(2):231–237.
   PubMed Web of Science ®Google Scholar
• Cao W, Li J, Hu C, et al. Symptom clusters and symptom interference of HCC patients undergoing TACE: a cross-sectional study in China. Support Care Cancer. 2013;21(2):475–483.
   PubMed Web of Science ®Google Scholar
• Miksad RA, Ogasawara S, Xia F, et al. Liver function changes after transarterial chemoembolization in US hepatocellular carcinoma patients: the LiverT study. BMC Cancer. 2019;19(1):795.
   PubMed Web of Science ®Google Scholar
• Ogasawara S, Ooka Y, Koroki K, et al. Switching to systemic therapy after locoregional treatment failure: definition and best timing. Clin Mol Hepatol. 2020;26(2):155–162.
   PubMed Web of Science ®Google Scholar
• Vogel A, Saborowski A. Current strategies for the treatment of intermediate and advanced hepatocellular carcinoma. Cancer Treat Rev. 2020;82:101946.
   PubMed Web of Science ®Google Scholar
• Marukuchi R, Furukawa K, Iwase R, et al. Risk factors for deterioration of remnant liver function after hepatic resection for hepatocellular carcinoma. Anticancer Res. 2019;39(10):5755–5760.
   PubMed Web of Science ®Google Scholar
• Lee HS, Park SY, Kim SK, et al. Thrombocytopenia represents a risk for deterioration of liver function after radiofrequency ablation in patients with hepatocellular carcinoma. Clin Mol Hepatol. 2012;18(3):302–308.
   PubMedGoogle Scholar
• Mercadante S, Aielli F, Adile C, et al. Sleep disturbances in patients with advanced cancer in different palliative care settings. J Pain Symptom Manage. 2015;50(6):786–792.
   PubMed Web of Science ®Google Scholar
• Shah C, Mramba LK, Bishnoi R, et al. Survival differences among patients with hepatocellular carcinoma based on the stage of disease and therapy received: pre and post sorafenib era. J Gastrointest Oncol. 2017;8(5):789–798.
   PubMed Web of Science ®Google Scholar
• Zhang X, El-Serag HB, Thrift AP. Predictors of five-year survival among patients with hepatocellular carcinoma in the United States: an analysis of SEER-Medicare. Cancer Causes Control. 2021;32(4):317–325.
   PubMed Web of Science ®Google Scholar
• Akbulut S, Ozer A, Saritas H, et al. Factors affecting anxiety, depression, and self-care ability in patients who have undergone liver transplantation. World J Gastroenterol. 2021;27(40):6967–6984.
   PubMed Web of Science ®Google Scholar
• Huang TW, Lin CC. The mediating effects of depression on sleep disturbance and fatigue: symptom clusters in patients with hepatocellular carcinoma. Cancer Nurs. 2009;32(5):398–403.
   PubMed Web of Science ®Google Scholar
• Chu TL, Yu WP, Chen SC, et al. Comparison of differences and determinants between presence and absence of sleep disturbance in hepatocellular carcinoma patients. Cancer Nurs. 2011;34(5):354–360.
   PubMed Web of Science ®Google Scholar